Search Result "HDAC10"
A Computational Approach to Investigate the HDAC6 and HDAC10 Binding Propensity of Psidium guajava-derived Compounds as Potential Anticancer Agents
Journal: Current Drug Discovery Technologies
Volume: 18 Issue: 3 Year: 2021 Page: 423-436
Author(s): Kayode Ezekiel Adewole,Ahmed Adebayo Ishola
DDX39B Predicts Poor Survival and Associated with Clinical Benefit of Anti-PD-L1 Therapy in ccRCC
Journal: Current Cancer Drug Targets
Volume: 21 Issue: 10 Year: 2021 Page: 849-859
Author(s): Jinhuan Wei,Jun Lu,Yun Cao,Gaosheng Yao,Yong Huang,Hongwei Zhao,Yihui Pan,Zihao Feng,Zhenhua Chen,Wei Chen,Junhang Luo,Jiazheng Cao
Different Sources of Bone Marrow Mesenchymal Stem Cells: AComparison of Subchondral, Mandibular, and Tibia Bone-derivedMesenchymal Stem Cells
Journal: Current Stem Cell Research & Therapy
Volume: 19 Issue: 7 Year: 2024 Page: 1029-1041
Author(s):
Structure, Functions and Selective Inhibitors of HDAC6
Journal: Current Topics in Medicinal Chemistry
Volume: 18 Issue: 28 Year: 2018 Page: 2429-2447
Author(s): Tao Liang,Hao Fang
Regulation of Runx2 by Histone Deacetylases in Bone
Journal: Current Protein & Peptide Science
Volume: 17 Issue: 4 Year: 2016 Page: 343-351
Author(s): Mohanakrishnan Vishal,Ramachandran Ajeetha,Rajendran Keerthana,Nagarajan Selvamurugan
Novel Approaches Towards Designing of Isoform-Selective Inhibitors Against Class II Histone Deacetylases: The Acute Requirement for Targetted Anticancer Therapy
Journal: Current Topics in Medicinal Chemistry
Volume: 16 Issue: 2 Year: 2016 Page: 2441-2452
Author(s): Shabir Ahmad Ganai
Potential Epigenetic Targets for Combating Alzheimerâs Disease
Journal: Mini-Reviews in Medicinal Chemistry
Volume: 21 Issue: 12 Year: 2021 Page: 1527-1540
Author(s): Dheeraj Pandey,Tiyas Pal,Abha Sharma,SJS Flora
HDAC9 as a Privileged Target: Reviewing its Role in Different Diseasesand Structure-activity Relationships (SARs) of its Inhibitors
Journal: Mini-Reviews in Medicinal Chemistry
Volume: 24 Issue: 7 Year: 2024 Page: 767-784
Author(s):
HDACs and HDAC Inhibitors in Urothelial Carcinoma â Perspectives for an Antineoplastic Treatment
Journal: Current Medicinal Chemistry
Volume: 24 Issue: 37 Year: 2017 Page: 4151-4165
Author(s): Maria Pinkerneil,Michele J. Hoffmann,Wolfgang A. Schulz,Gunter Niegisch
Preclinical and Clinical Studies of Chidamide (CS055/HBI-8000), An Orally Available Subtype-selective HDAC Inhibitor for Cancer Therapy
Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 17 Issue: 6 Year: 2017 Page: 802-812
Author(s): Shuai Gao,Xiaoyang Li,Jie Zang,Wenfang Xu,Yingjie Zhang